PSYCHOPHARMACOLOGICAL PROFILE OF CLENBUTEROL

被引：37

作者：

FRANCES, H

PONCELET, M

DANTI, S

GOLDSCHMIDT, P

SIMON, P

机构：

来源：

DRUG DEVELOPMENT RESEARCH | 1983年 / 3卷 / 04期

关键词：

D O I：

10.1002/ddr.430030407

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：349 / 356

页数：8

共 37 条

[1]

ASKEW BM, 1963, LIFE SCI, P725

[2] DEVELOPMENT OF BETA-ADRENERGIC-RECEPTOR SUBSENSITIVITY BY ANTIDEPRESSANTS [J].

BANERJEE, SP ;

KUNG, LS ;

RIGGI, SJ ;

CHANDA, SK .

NATURE, 1977, 268 (5619) :455-456

[3]

BOISSIER JR, 1965, ARCH INT PHARMACOD T, V158, P212

[4]

BOISSIER JR, 1961, THERAPIE, V16, P279

[5] EVIDENCE THAT SYSTEMICALLY ADMINISTERED SALBUTAMOL REDUCES FOOD-INTAKE IN RATS BY ACTING ON CENTRAL BETA-ADRENERGIC SITES [J].

BORSINI, F ;

BENDOTTI, C ;

THURLBY, P ;

SAMANIN, R .

LIFE SCIENCES, 1982, 30 (11) :905-911

[6] DEVELOPMENT OF CORTICAL BETA-ADRENOCEPTOR SUBSENSITIVITY IN RAT BY CHRONIC TREATMENT WITH TRAZODONE, DOXEPIN AND MIANSERINE [J].

CLEMENTSJEWERY, S .

NEUROPHARMACOLOGY, 1978, 17 (09) :779-781

[7]

DELINISTULA A, 1979, ARCH PHARM, V307, P258

[8]

DUMEUR G, 1978, 7TH INT C PHARM IUPH

[9]

ENGELHARDT G, 1976, ARZNEIMITTEL-FORSCH, V26, P1404

[10]

FRANCES H, 1978, J PHARMACOL-PARIS, V9, P25

← 1 2 3 4 →